摘要
缺口信号途径是一种高度的保护系统,它控制了胚胎细胞命运的决定和通过影响相邻细胞的交流来控制成熟干细胞的维持。这种途径与由于增加的细胞增殖和肿瘤血液灌注除此之外还有抑制细胞凋亡引起的各种癌症的发展有关联。医药代表压制过于活跃的缺口信号也许有利于癌症病人的治疗。这些定向的疗法比较常规的抗癌疗法包括减少对正常细胞的影响有更多的有利条件。在这个综述中,我们探索在癌症中定向的缺口信号途径的基本原理和调查研究的策略旨在阻止该通路。
关键词: 癌症,单克隆抗体,缺口抑制,缺口信号,分泌酶抑制剂
图形摘要
Current Cancer Drug Targets
Title:Notch Signaling in Cancer: Rationale and Strategies for Targeting
Volume: 15 Issue: 5
Author(s): Aisha Alketbi and Samir Attoub
Affiliation:
关键词: 癌症,单克隆抗体,缺口抑制,缺口信号,分泌酶抑制剂
摘要: The Notch signaling pathway is a highly conserved system that controls embryonic cell fate decisions and the maintenance of adult stem cells through affecting communication between adjacent cells. The pathway is linked to the development of various cancers owing to increased cell proliferation and tumor blood perfusion in addition to inhibition of apoptosis. Pharmaceutical agents that suppress overactive Notch signaling may be of benefit in the treatment of patients with various cancers. These targeted therapies confer several advantages over conventional anticancer therapies including reduced deleterious effects on normal cells. In this review, we explore the rationale for targeting the Notch signaling pathway in cancer along with different investigational strategies designed to block the pathway.
Export Options
About this article
Cite this article as:
Aisha Alketbi and Samir Attoub , Notch Signaling in Cancer: Rationale and Strategies for Targeting, Current Cancer Drug Targets 2015; 15 (5) . https://dx.doi.org/10.2174/156800961505150710113353
DOI https://dx.doi.org/10.2174/156800961505150710113353 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evidence of Association between Epstein Barr Virus Serum Antibodies with HAs and RI as Biomarkers of Active Rheumatoid Arthritis
Current Biomarkers (Discontinued) Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders
Current Cancer Therapy Reviews Virus-Based RNA Silencing Agents and Virus-Derived Expression Vectors as Gene Therapy Vehicles
Recent Patents on Biotechnology Theranostic Platforms Proposed for Cancerous Stem Cells: A Review
Current Stem Cell Research & Therapy Nanohybrids of Dendrimers and Carbon Nanotubes: A Benefaction or Forfeit in Drug Delivery?
Nanoscience & Nanotechnology-Asia Colorectal Cancer – Increased Multidimensional Understanding of the Molecular Genesis
Current Cancer Therapy Reviews The Review of the Synthesis of Bestatin, an Effective Inhibitor of Aminopeptidase N
Mini-Reviews in Organic Chemistry Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Current Medicinal Chemistry Antibody Penetration Into Living Cells: Pathogenic, Preventive and Immuno-Therapeutic Implications
Current Pharmaceutical Design Dendritic Cell-Based Immunotherapy in Thyroid Malignancies
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Ion Exchange Resins Transforming Drug Delivery Systems
Current Drug Delivery Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways
Current Neuropharmacology Metabolism of Flavonoids in Human: A Comprehensive Review
Current Drug Metabolism Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets Viral and Non-Viral Methods to Genetically Modify Dendritic Cells
Current Gene Therapy Formulation and Evaluation of in vitro Cytotoxicity of Carboplatin Niosomes
Drug Delivery Letters Treatment of Elderly Patients Affected by Lung Cancer: Why to Treat, when to Treat and what we Know
Anti-Cancer Agents in Medicinal Chemistry Current and Potential Anticancer Drugs Targeting Members of the UHRF1 Complex Including Epigenetic Modifiers
Recent Patents on Anti-Cancer Drug Discovery Technetium Labeled Small Peptide Radiopharmaceuticals in the Identification of Lung Cancer
Current Pharmaceutical Design Cell Cycle Regulatory Kinase Modulators: Interim Progress and Issues
Current Topics in Medicinal Chemistry